Foreign
COVID-19: Trump Approves Remdesivir To Boost Recovery
More than 3.3 million cases of infection have been officially diagnosed in 195 countries, including 1.5 million in Europe alone. That number is likely only a fraction of true cases as testing is still limited.
The United States has the most deaths with more than 65,000, followed by Italy with 28,236, the United Kingdom with 27,510, Spain with 25,100 deaths and France with 24,594 fatalities.
US President Donald Trump on Friday announced that Remdesivir, an antiviral drug initially developed to treat Ebola, was given the green light for use after a major trial found that it boosted recovery in serious COVID-19 patients.
“It’s really a very promising situation,” Trump said on Friday at the White House.
The drug incorporates itself into the virus’s genome, short-circuiting its replication process.
Its approval came as the US leaders struggled with growing pressure from citizens wearying of stay-at-home orders.
Trump is keen for a turnaround as the world’s largest economy reels with tens of millions left jobless.
- AFP